Article Details

Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational ...

Retrieved on: 2021-08-04 19:52:30

Tags for this article:

Click the tags to see associated articles and topics

Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational .... View article details on hiswai:

Excerpt

... Phase 1 clinical trial of FT538 in combination with the CD38-targeted monoclonal antibody daratumumab in patients with relapsed / refractory AML, ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up